Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7706869 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL599581 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL599481 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL22408893 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL22408899 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL19064977 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL11171482 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL536992 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL22444981 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB | |
| SCHEMBL28098968 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRCES2MEN1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041663-A1 | PREVENTION OF ROSACEA INFLAMMATION | UNIV CALIFORNIA (US) | 2026-02-12 | — | — | US | claimed |
| US-12285404-B2 | Prevention of rosacea inflammation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-29 | — | — | US | claimed |
| US-20230181518-A1 | PREVENTION OF ROSACEA INFLAMMATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-06-15 | — | — | US | claimed |
| US-11382890-B2 | Prevention of rosacea inflammation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-07-12 | — | — | US | claimed |
| EP-0934078-B1 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORP (US) | 2002-12-18 | — | — | EP | claimed |
| US-6004578-A | FOR ENHANCING THE PERCUTANEOUS ABSORPTION OF DRUGS WHEN ADMINISTERED TO A BODY SURFACE OR MEMBRANE | ALZA CORPORATION (US) | 1999-12-21 | — | — | US | claimed |
| EP-0934078-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998017315-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1998-04-30 | — | — | WO | claimed |
| US-20260083685-A1 | METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | disclosed |
| US-20260041663-A1 | PREVENTION OF ROSACEA INFLAMMATION | UNIV CALIFORNIA (US) | 2026-02-12 | — | — | US | disclosed |
| US-12514828-B2 | Methods of permeabilizing the blood brain barrier | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250213646-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN | L'OREAL (FR) | 2025-07-03 | — | — | US | disclosed |
| US-20250186472-A1 | COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS | Neonc Technologies, Inc. | 2025-06-12 | — | — | US | disclosed |
| WO-2022082093-A1 | COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS | Neonc Technologies, Inc. (US) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022082218-A1 | IMPROVED DERMATOLOGICAL COMPOSITIONS AND USES THEREOF | BABAPOUR REZA (US) | 2022-04-21 | — | — | WO | disclosed |
| EP-0934078-B1 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORP (US) | 2002-12-18 | — | — | EP | disclosed |
| US-6004578-A | FOR ENHANCING THE PERCUTANEOUS ABSORPTION OF DRUGS WHEN ADMINISTERED TO A BODY SURFACE OR MEMBRANE | ALZA CORPORATION (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0934078-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998017315-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186472-A1 | COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS | CFH, AQP4, MAG | ALDH1A1 2939/4885TSHR 4486/4885CES2 345/4885 |
| US-20260083685-A1 | METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER | CD4, EPCAM, ICOS | ALDH1A1 1230/4885TSHR 219/4885CES2 323/4885 |
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | ALDH1A1 4486/4885TSHR 1854/4885CES2 2591/4885 |
| US-20260041663-A1 | PREVENTION OF ROSACEA INFLAMMATION | CPA3, CTSD, TPSD1 | ALDH1A1 2072/4885TSHR 2866/4885CES2 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.